Just caught wind that Morgan Stanley bumped up their NTR rating back in January from Equal-Weight to Overweight, but here's the thing - they're still calling for around 26% downside to $49. Nutrien's trading at $66 right now, so the math doesn't quite add up with their bullish stance. Revenue projections look solid though, up nearly 37% with EPS around $7.08.

What's interesting is the institutional money flow on NTR. We've got 978 funds holding positions, and while that's down slightly from last quarter, some big players are making moves. Royal Bank of Canada loaded up another 2.2M shares, now sitting on 7.19% of the company. Bank of Montreal also increased their stake by over 12%, though both are trimming their overall portfolio weight in NTR. Arrowstreet Capital's actually doubling down - up 16% in shares and increasing their allocation.

The put/call ratio sitting at 2.42 tells me the market's still pretty bearish on NTR despite the upgrade. Institutional flows are mixed - some accumulating, others taking profits. Worth watching how this plays out over the next quarter.